Header image

RECOMBINANT POLYCLONAL ANTIBODIES: SHOWCASING GRIFOLS' PROPRIETARY PLATFORM AS A CASE STUDY IN GAINING CAPABILITIES VIA EXTERNAL INNOVATION

Tracks
SEVERO OCHOA ROOM
Tuesday, October 7, 2025
14:30 - 15:15
SEVERO OCHOA ROOM

Overview

Sponsor GRIFOLS


Details

This session explores strategies used by the pharmaceutical industry to gain capabilities through external innovation, as well as approaches Biotechs companies use to expand via platform-based growth. Jose Terencio, SVP Discovery at Grifols, and Laia Crespo, Partner at Sanofi Ventures, will share their experience with strategic alignment, investment models, acquisition decisions, integration process and pipeline impact using Grifols' proprietary platform of recombinant polyclonal antibodies as a case study.


Details

Agenda Item Image
Grifols .

Sponsor

Dr Laia Crespo
Partner
Sanofi Ventures

Moderator

Dr Jose Terencio
SVP Discovery
Grifols

Speaker

 


BACK TO AGENDA HOME




HOME ATTEND EXHIBIT PARTNERING SPONSORS MEDIA TRAVEL
loading